Agra Ventures Ltd. (AGFAF) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Agra Ventures Ltd.

AGFAF

OTC

Unprofitable

EPS improving

Unprofitable

EPS improving

322007

Drug Manufacturers - Specialty & Generic

Next Earning date - 04 Aug 2025

322007

Drug Manufacturers - Specialty & Generic

Next Earning date - 04 Aug 2025

0.01USD

-0.00 ( -5.81%)

Market Open

Relative Strenght

Volume Buzz

-33%

Earning Acce

Dist 52w H.

49%

Overview Chart

Quote Panel

Updated June 17, 2025

1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y 69.40 %

Key Metrics

Market Cap
322007
Shares Outstanding
22.06M
Share in Float
17.31M
Dividende
0

Earning Date
04 Aug 2025
Price Target
0.0146
Average Volume
5951.08642
Beta
2.116

Range
0.0076-0.02856
Industry
Drug Manufacturers - Specialty & Generic
Website
https://agraventures.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.88x

P/S Ratio

-0.01x

P/B Ratio

-1.0

Debt/Equity

-5863.3%

Net Margin

$0.6

EPS

How AGFAF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

AGFAF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

AGFAF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-6.48
vs -107.71

Q1.23

-100%

0.01
vs 2.07

Q2.23

+115%

0.48
vs -3.23

Q3.23

+113%

0.08
vs -0.64

Q4.23

+105%

0.32
vs -6.48

Q1.24

N/A

-0.00
vs 0.01

Q2.24

N/A

-0.00
vs 0.48

Q3.24

N/A

-0.01
vs 0.08

Q4.24

N/A

-0.01
vs 0.32

Q1.25

+100%

NA
vs -0.00

Sales Growth

YoY

Current

Estimates

Q4.22

+19%

181.8K vs 153K

Q1.23

-27%

132.6K vs 181.6K

Q2.23

+4%

142.8K vs 137.2K

Q3.23

-34%

113.7K vs 172.8K

Q4.23

-314%

-389000.00 vs 181.8K

Q1.24

-100%

NA vs 132.6K

Q2.24

-100%

NA vs 142.8K

Q3.24

-100%

NA vs 113.7K

Q4.24

+100%

NA vs -389000

Q1.25

NA vs NA

Return on Equity

QoQ

Q3.21

-2%

-0.02
vs -0.16

Q4.21

-18%

-0.18
vs -0.02

Q1.22

+7%

0.07
vs -0.18

Q2.22

-27%

-0.27
vs 0.07

Q3.22

-18%

-0.18
vs -0.27

Q4.22

+198%

1.98
vs -0.18

Q1.23

-5%

-0.05
vs 1.98

Q2.23

-27%

-0.27
vs -0.05

Institutionnal Ownership

Earnings Growth

Latest News

globenewswire.com

13 hours ago

Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.

globenewswire.com

16 hours ago

Digicann Ventures Provides Update Regarding Proposed RTO Transaction

globenewswire.com

17 hours ago

Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures

globenewswire.com

17 hours ago

Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction

globenewswire.com

18 hours ago

Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures

globenewswire.com

21 hours ago

Digicann Ventures Grants Restricted Share Units